Cargando…

Structural basis for activation of CB1 by an endocannabinoid analog

Endocannabinoids (eCBs) are endogenous ligands of the cannabinoid receptor 1 (CB1), a G protein-coupled receptor that regulates a number of therapeutically relevant physiological responses. Hence, understanding the structural and functional consequences of eCB-CB1 interactions has important implicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishna Kumar, Kaavya, Robertson, Michael J., Thadhani, Elina, Wang, Haoqing, Suomivuori, Carl-Mikael, Powers, Alexander S., Ji, Lipin, Nikas, Spyros P., Dror, Ron O., Inoue, Asuka, Makriyannis, Alexandros, Skiniotis, Georgios, Kobilka, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169858/ https://www.ncbi.nlm.nih.gov/pubmed/37160876 http://dx.doi.org/10.1038/s41467-023-37864-4

Ejemplares similares

Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor
por: Alapafuja, Shakiru O., et al.
Publicado: (2019)

Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats
por: Spyridakos, Dimitris, et al.
Publicado: (2022)

Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands
por: Gaitán, Adriana V, et al.
Publicado: (2019)

Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2018)

Conformational transitions of a neurotensin receptor 1–G(i1) protein complex
por: Kato, Hideaki E., et al.
Publicado: (2019)

Targeting the Endocannabinoid System for Neuroprotection: A (19)F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA
por: Zhuang, Jianqin, et al.
Publicado: (2013)

Endocannabinoid Signaling Regulates Sleep Stability
por: Pava, Matthew J., et al.
Publicado: (2016)

Therapeutic Opportunities through the Modulation of Endocannabinoid Transport
por: Guo, Jason J, et al.
Publicado: (2013)

Atypical structural snapshots of human cytomegalovirus GPCR interactions with host G proteins
por: Tsutsumi, Naotaka, et al.
Publicado: (2022)

Endocannabinoid Metabolome Characterization of Transitional and Mature Human Milk
por: Gaitán, Adriana V., et al.
Publicado: (2018)

Endocannabinoid engagement of CB(2) regulates RSV-induced immunity
por: Kaplan, Barbara L. F.
Publicado: (2018)

Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells
por: Jiang, Shuxian, et al.
Publicado: (2007)

Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans
por: Emendato, Alessandro, et al.
Publicado: (2018)

Pharmacological characterization of the endocannabinoid sensor GRAB(eCB2.0)
por: Singh, Simar, et al.
Publicado: (2023)

Myeloid But Not Endothelial Expression of the CB2 Receptor Promotes Atherogenesis in the Context of Elevated Levels of the Endocannabinoid 2-Arachidonoylglycerol
por: Avraamidou, Elina, et al.
Publicado: (2022)

Cannabinoid CB(1) Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity
por: Argueta, Donovan A., et al.
Publicado: (2019)

PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
por: Gardner, Eliot L., et al.
Publicado: (2016)

Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy
por: Iannotti, Fabio A., et al.
Publicado: (2018)

Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking
por: Gamaleddin, Islam, et al.
Publicado: (2012)

Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior
por: Argue, Kathryn J, et al.
Publicado: (2017)

Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader–Willi syndrome
por: Knani, Ibrahim, et al.
Publicado: (2016)

Alcohol Binge-Induced Cardiovascular Dysfunction Involves Endocannabinoid–CB1-R Signaling
por: Paloczi, Janos, et al.
Publicado: (2019)

Synthesis of Functionalized Cannabilactones
por: Liu, Yingpeng, et al.
Publicado: (2020)

Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina
por: Papadogkonaki, Sofia, et al.
Publicado: (2023)

Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB(1) content of axon terminals
por: Lenkey, Nora, et al.
Publicado: (2015)

Downregulation of the CB1-Mediated Endocannabinoid Signaling Underlies D-Galactose-Induced Memory Impairment
por: Li, Ranran, et al.
Publicado: (2020)

Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB(1) Receptor Activation
por: Miklós, Zsuzsanna, et al.
Publicado: (2021)

Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?
por: Kunos, George, et al.
Publicado: (2022)

Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
por: Wang, Haoqing, et al.
Publicado: (2022)

A peripheral CB(2) cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB(2) reporter mouse
por: Lin, Xiaoyan, et al.
Publicado: (2022)

Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
por: Murphy, Thomas, et al.
Publicado: (2020)

Fine-tuning of synaptic upscaling at excitatory synapses by endocannabinoid signaling is mediated via the CB1 receptor
por: Song, Yunping, et al.
Publicado: (2015)

Corrigendum: Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB(1) content of axon terminals
por: Lenkey, Nora, et al.
Publicado: (2015)

Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis
por: Dickens, Alex M., et al.
Publicado: (2020)

Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor
por: Shim, Joong-Youn
Publicado: (2021)

Endocannabinoids regulate cocaine-associated memory through brain AEA–CB1R signalling activation
por: Li, Hongchun, et al.
Publicado: (2022)

Endocannabinoid-LTP Mediated by CB1 and TRPV1 Receptors Encodes for Limited Occurrences of Coincident Activity in Neocortex
por: Cui, Yihui, et al.
Publicado: (2018)

Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin
por: Kalkan, Hilal, et al.
Publicado: (2023)

Analogous modulation of inflammatory responses by the endocannabinoid system in periodontal ligament cells and microglia
por: Jäger, Andreas, et al.
Publicado: (2020)

Structure of the Neurotensin Receptor 1 in complex with β-arrestin 1
por: Huang, Weijiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3cphb887n7qa51c0qjucq4hajd